Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race

Abstract

Aims

The aims of this study are to confirm disparities in diabetes mortality rates based on race, determine if race predicts combinations of diabetes and multiple chronic conditions (MCC) that are leading causes of death (LCD), and determine if combinations of diabetes plus MCC mediate the relationship between race and mortality.

Methods

We performed a retrospective cohort study of 443,932 Medicare beneficiaries in the State of Michigan with type 2 diabetes mellitus and MCC. We applied Cox proportional hazards regression to determine predictors of mortality. We applied multinomial logistic regression to determine predictors of MCC combinations.

Results

We found that race influences mortality in Medicare beneficiaries with Type 2 diabetes mellitus and MCC. Prior to adjusting for MCC combinations, we observed that Blacks and American Indian/Alaska Natives have increased risk of mortality compared to Whites, while there is no difference in mortality between Hispanics and Whites. Regarding MCC combinations, Black/African American beneficiaries experience increased odds for most MCC combinations while Asian/Pacific Islanders and Hispanics experience lower odds for MCC combinations, compared to Whites. When adjusting for MCC, mortality disparities observed between Whites, Black/African Americans, and American Indians/Alaska Natives persist.

Conclusions

Compared to Whites, Black/African Americans in our cohort had increased odds of most MCC combinations, and an increased risk of mortality that persisted even after adjusting for MCC combinations.

Introduction

Diabetes is one of the most common chronic diseases, affecting 30 million people in the United States, with Type 2 diabetes mellitus (hereinafter referred to as diabetes) being the most common [1]. Its prevalence increases every year [2] and over the past two decades has reached epidemic proportions, being a major cause of morbidity and mortality in the United States [3], [4]. Many studies describe disparities in diabetes prevalence, incidence, and mortality among different race and ethnicity groups, with increased rates observed in racial and ethnic minority groups [5], [6], [7], [8]. While disparities due to diabetes alone are well-described, less understood are disparities related to other chronic conditions associated with diabetes, including combinations of these comorbidities. Using claims data from a cohort of Medicare beneficiaries in the State of Michigan, the aims of this study are three-fold:

• Confirm disparities in diabetes mortality rates based on race;

• Determine if race is predictive of combinations of diabetes and multiple chronic conditions (MCC) that are leading causes of death (LCD); and

• Determine if combinations of diabetes plus MCC mediate the relationship between race and mortality.

Several studies provide evidence that racial and ethnic minorities experience diabetes-related mortality at higher rates compared to whites. For instance, Golden et al. [9] found that Black, Native Americans and Alaskan Natives, and Hispanics exhibit 2.3, 1.9, and 1.5 times greater mortality related to diabetes, respectively, than their White counterparts. Other studies [10], [11], [12] report similar increases in mortality among Blacks explained by economic inequality and segregation [10], as well as socioeconomic status [11]. These studies suggest that access to health care, which is a key disadvantage for minority populations, does not solely account for the increased diabetes-only mortality rates among racial and ethnic minorities. However, a review of the literature shows an incomplete understanding of the relationship between race/ethnicity and diabetes-only mortality, especially when accounting for various confounding factors that could contribute to such disparities.

Diabetes is comorbid with MCC that are LCD in the United States, including cardiovascular disease (CVD), chronic kidney disease (CKD), cancer, chronic obstructive pulmonary disease (COPD), Alzheimer’s disease (AD), and stroke [13]. Certain combinations of diabetes and chronic conditions, such as diabetes and CHF, or diabetes and CKD, have been well studied, and thus there is extensive literature on racial and ethnic disparities in the development of these chronic conditions in patients with diabetes. Racial and ethnic minorities, particularly Hispanics and Blacks, exhibit increased rates of diabetes-related CKD compared to Whites [9], [14]. In addition, Hispanics and African Americans with diabetes have a higher prevalence of early CKD compared to Whites, with some evidence that Blacks experience a more rapid decline in renal function compared to Whites once they develop proteinuria [15], [16].

While racial and ethnic minorities experience greater rates of CKD with diabetes, the combination of diabetes and congestive heart failure (CHF) is more prevalent in Whites. Whites with diabetes are more likely to develop CHF or other cardiovascular complications compared to racial and ethnic minority populations [14], as one study demonstrated that increasing levels of HbA1c, used as a measure of progressing diabetes, increased the risk of developing CHF in Whites compared to racial and ethnic minorities [17]. Wong et al. [18] reported that Hispanic and Black populations with diabetes are at lower risk of developing cardiovascular disease than Whites with diabetes.

The risks of comorbid cancer, COPD, Stroke and AD are less well described. A few studies report that Blacks and Hispanics with diabetes are at increased risk for liver or colorectal cancer [19], [20], [21], while breast cancer is not more prevalent in any racial or ethnic subgroup [22]. A systematic review by Gläser et al. [23] found that diabetes can worsen the progression and prognosis of COPD, while Davis et al. [24] reported that among adults aged 60–79, Blacks had twice the prevalence of diabetes plus COPD as other racial and ethnic populations. Data regarding stroke in combination with diabetes is not well described, with some studies reporting higher rates of stroke among Blacks and Hispanics, but they leave open the possibility that this could be due to minority populations exhibiting higher rates of stroke and diabetes in general [5], [25], [26]. Another study found that racial and ethnic minority populations were at lower risk of developing all forms of diabetic cardiovascular disease, including stroke [27]. Finally, there is an even larger gap in the understanding of the relationship between diabetes and AD. One study demonstrates that uncontrolled diabetes increases the risk of AD, however it did not discuss racial or ethnic disparities related to risk [28]. Another study demonstrated that diabetes led to increases in cognitive decline in old age, but there was no difference in cognitive decline between Blacks and Whites [29].

The literature summarized here describes disparities between racial and ethnic groups in the context of the relationship between diabetes and individual chronic conditions. However, little is known about disparities between racial and ethnic groups in diabetes plus MCC (i.e. more than one additional chronic condition). One study found that minority diabetic patients are more likely to be diagnosed with end-stage diabetic nephropathy, but they have fewer other conditions such as CVD, COPD and cancer [30]. Young et al. [30] found that the risk of CVD-related mortality in non-Hispanic whites with diabetes was higher than that of minorities. Davis et al. [24] reported that the co-occurrence of diabetes, CVD and cancer amongst Hispanics, non-Hispanic blacks and Whites increased with age; however, non-Hispanic Whites had lower prevalence of these comorbidities compared to minorities.

Little research exists that focuses on the relationship between diabetes and multiple chronic conditions and mortality. Individuals with diabetes have an increased risk of developing other chronic conditions, and vice versa, that can lead to death at a more rapid rate than those without these conditions [31], [32]. Determining whether there is a racial component and how other factors affect diabetes-related mortality is essential for a more complete understanding of diabetes-related mortality. Using Medicare claims data for Michigan beneficiaries with Type 2 diabetes mellitus, we aim to determine if race and various demographic characteristics influence mortality and combinations of diabetes and various chronic conditions, and whether the presence of multiple chronic conditions mediates the relationship between race/ethnicity and mortality (see Fig. 1 for our conceptual model).